Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Fortrea Holdings Inc (FTRE)

  • Business News
  • Nov. 24, 2025, 12:00 UTC
  • 13
  • 1 comments

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

Market reaction Comment Full text

Kymera Therapeutics Inc (KYMR)

  • Business News
  • Nov. 24, 2025, 12:00 UTC
  • 19
  • 1 comments

Kymera Therapeutics to Participate in Upcoming December Investor Conferences

Market reaction Comment Full text

Cardiff Oncology Inc. (CRDF)

  • Business News
  • Nov. 24, 2025, 12:00 UTC
  • 13
  • 1 comments

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

Market reaction Comment Full text

Bristol-Myers Squibb Company (BMY)

  • Business News
  • Nov. 24, 2025, 11:59 UTC
  • 9
  • 1 comments

Bristol Myers Squibb - Bristol Myers Squibb to Host Hematology-Focused Investor Event

Market reaction Comment Full text

Bristol-Myers Squibb Company (BMY)

  • Business News
  • Nov. 24, 2025, 11:59 UTC
  • 17
  • 1 comments

Bristol Myers Squibb to Host Hematology-Focused Investor Event

Market reaction Comment Full text

Bristol-Myers Squibb Co. (BMYMP)

  • Business News
  • Nov. 24, 2025, 11:59 UTC
  • 16
  • 1 comments

Bristol Myers Squibb to Host Hematology-Focused Investor Event

Market reaction Comment Full text

Becton Dickinson and Company (BDX)

  • Business News
  • Nov. 24, 2025, 11:50 UTC
  • 10
  • 1 comments

BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

Market reaction Comment Full text

Merck & Company Inc (MRK)

  • Business News
  • Nov. 24, 2025, 11:46 UTC
  • 9
  • 1 comments

Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches

Market reaction Comment Full text

Enlivex Therapeutics Ltd. (ENLV)

  • Business News
  • Nov. 24, 2025, 11:40 UTC
  • 12
  • 1 comments

Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis

Market reaction Comment Full text

Novo Nordisk (NVO)

  • Business News
  • Nov. 24, 2025, 11:25 UTC
  • 7
  • 1 comments

Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimers disease progression

Market reaction Comment Full text
  • Previous
  • 533
  • 534
  • 535
  • 536
  • 537
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin